Alpinea galanga (L) Extracts Decreases TSH Levels and Balances
tri-iodothyronine (T3), Thyroxine (T4) levels with protective effect on Thyroid Tissue in Wistar Rats with Thyroid Disorder
Ritu Sanwal1, Madan Lal Kaushik2, Shradha Bisht3
1Research Scholar, Adarsh Vijendra Institute of Pharmaceutical Sciences (AVIPS), Shobhit University, Gangoh.
2Professor, Adarsh Vijendra Institute of Pharmaceutical Sciences (AVIPS), Shobhit University, Gangoh.
3Associate Professor, Babu Banarasi Das Northern India Institute of Technology (BBDNIIT), Lucknow.
*Corresponding Author E-mail: sanwalritu4@gmail.com
ABSTRACT:
In India Endocrine disorders, especially thyroid disorders are prevailing. Among different thyroid disorders hypothyroidism precedes and stands as a challenge in our society. There is a strong need to control its prevalence because it majorly contributes to a large number of chronic disorders. Presently the major choice of therapy is intake of Thyroxine hormone. However there are various alternative medicines, specifically herbal treatments, being reported in the literature and now a day’s the authentic investigation of such herbal treatments is gaining popularity. Present study explores the anti- hypothyroid potential of Alpinea Galanga (L) rhizome extracts. The rhizome extracts were prepared and Acute toxicity studies (425) were performed. Hypothyroidism was induced in female albino rats using Propylthiouracil (PTU) at a dose of 60µg/kg bodyweight orally for one month. Hypothyroidism was confirmed by increased TSH levels in blood. Those animals which were exposed to PTU were treated with standard thyroxine at a dose of 10µg/kg bodyweight by oral route and different extracts were given at a dose of 200mg/kg bodyweight by oral route to their respective groups. Treatment was carried for two months. Methanolic extract at dose of 200mg/kg bodyweight was found more effective in restoring the elevated levels of TSH when compared to the other treated groups. The results of extract indicate less damage to the follicles of thyroid tissue which shows minimizing effect of Alpinea Galanga (L) rhizome extracts over PTU induced Hypothyroidism. Histopathological examination shows the restoration of thyroid follicles by Thyroxine hormone and Rhizome extracts as compared to untreated groups. This study depicts the Thyroid protective and enhancing property of Alpinea Galanga (L) rhizome extracts by lowering TSH levels and by reducing damage to thyroid tissues.
KEYWORDS: Alpinea Galanga (L), Hypothyroidism, Thyroid stimulating Hormone, Propylthiouracil, Thyroxine.
INTRODUCTION:
Hypothyroidism is a hypo metabolic clinical state resulting from inadequate production of thyroid hormones for prolonged periods, or rarely, from resistance of the peripheral tissues to the effects of thyroid hormones1.
Alpinia galangal (L) Willd.(Family- Zingiberaceae), a perennial, aromatic, rhizomatous herb used in both traditional as well as in modern system of medicine to treat various physiological conditions. It is an important source of various types of compounds with diverse chemical structures as well as pharmacological activities2-3.
Chemical constituents:
The earlier studies reveals the presence of various phytochemicals in the rhizomes of Alpinia galangal, which includes terpenoidal moieties, the pungent principal compounds such as 1’S’-1’-acetoxychavicol acetate4-6. The rhizome also contains flavonoids, some of which have been identified as kaemperol, kaempferide, galangin and alpinin. Kaempferide, galangin and alpinin. The rhizome of Alpinia galanga posses Anti-inflammatory, analgesic, hypoglycemic, hypolipidemic, anti-allergic, anti-microbial and anti-platelet activity7-13. As the plant is rich in various polyphenols and exhibits different pharmacological properties, which encouraged us to investigate Alpinia galangal rhizome for its efficacy in management of hypothyroidism.
MATERIAL AND METHODS:
Drugs and chemicals:
Propylthiouracil (PTU) and L-thyroxine were purchased from Sigma- Aldrich. All the solvents and other chemicals used were analytical grade.
Experimental animals:
Forty two female Wistar rats (weighing approximately 150-200g) were procured from animal house of the Institute, maintained under standard conditions in the animal house room at 25.0oC± 2.0oC, Relative Humidity 55.0% ± 5.0% with 12h light: 12h dark cycles with a standard pellet diet and water ad libitum. The animal handling and experimental procedures were performed in accordance to the Committee for the purpose of control and supervision of Experiments on Animals (CPCSEA) guidelines and Institutional Animal Ethical Committee (IAEC), Siddhatha Institute of Pharmacy, Dehradun, Uttarakhand (India) approved experimental protocol (Ref. - SIP/IAEC/PCOL/08/2019).
Collection and Authentication of Plant material:
Rhizome part of Alpinia galanga was obtained from a commercial supplier and authenticated by Dr. Sunita Garg, Emeritus Scientist, RHMD (Raw material Herbarium and Museum), CSIR-NISCAIR, New Delhi. A voucher specimen has been deposited at the NISCAIR Herbarium (Ref no. NISCAIR/RHMD/Consult/2019/3524-25-2).
Extraction of plant material:
Preparation of Extracts:
Fresh Rhizome of Alpinia galanga were shade dried and powdered coarsely in a grinder. The powder plant material (500g) was extracted by hot percolation method using soxhlet apparatus with Petroleum ether (make -Thermo Fischer Scientific). The marc of Pet. Ether extraction was further successively extracted by methanol followed by water using cold maceration technique for 72 hrs with regular stirring. After 72 h, the extract was filtered and fresh solvent was added and stirred for next 72 hrs. This procedure was repeated for 2 more times with the fresh solvent. Afterwards the extract was filtered and concentrated under reduced pressure. The concentrated extract was stored at 4oC for further examinations.
Phytochemical Screening:
Preliminary phytochemical screening of the extracts was done to test the presence of active constituents such as carbohydrates, glycosides, alkaloids, flavonoids, tannins, terpenoids, saponins.13
Acute Oral toxicity Study:
An acute oral toxicity study was carried out according to OECD guideline 425. Six Female Wistar strain rats weighing 150-200gm, were administered 2000mg/kg of test solution. After administration of test solution the rats were observed for behavioral changes and mortality at the interval of 0.5 h, I h, 2 h, 4 h, 24 h, 48 h and 72 h and lastly upto 14 days.
Induction of Hypothyroidism:
Hypothyroidism was induced by oral dose of PTU (60µg/kg body weight) in drinking water of Female Wistar Rats for one month. After one month hypothyroidism was confirmed by elevated serum TSH level.14
Experimental design:
Female wistar rats were divided into 6 groups containing 6 animals each. Group I (normal control) were fed with standard diet and water and were not given any treatment; Group II, III, IV, V and VI receives propylthiouracil (PTU) at a dose of 60µg/kg body weight orally daily upto the induction of disease. Group II serves as disease control and receives only PTU. Group III serves as Standard control and receives PTU and standard drug Levothyroxine (10µg/kg) orally. Group IV, V and VI serves as test groups and receives PTU and test extracts orally with doses of 200mg/kg of each extract respectively.
The body weight and temperature of Rats of all the groups were measured at an interval of 1 week and at the end of 1 month thyroid function test was performed. Total duration of research protocol was two months. At the end of second month, animals were subjected to high dose of thiopental sodium, and then blood was collected from retro-orbital plexus and serum was separated by centrifugation at 2500rpm for 10min. Biochemical parameters of the separated serum were assayed in pathological laboratory.
Histopathological studies:
Thyroid tissue isolated from all experimental groups were fixed in 20% formalin and embedded in paraffin wax. Microtome section of 5-6 micron thickness were cut and stained with haematoxylineosin (H&E) dye. These sections were examined under the Brightfield microscope, for altered histopathological changes in test and control group.
Statistical analysis:
Results are reported as Mean± SEM. The analysis was performed using Graph pad prism version 7 with one-way analysis of variance (ANOVA) followed by Tukey’s test. P value <0.05 were considered statistically significant.
RESULTS:
Phytochemical screening:
Preliminary phytochemical screening shows that the methanolic extract contains flavonoids, triterpenoids, carbohydrates, alkaloids, phenolics and tannins.
Acute oral toxicity study:
Extracts of Alpinia galanga did not show any sign of toxicity or mortality at a dose level of 2000 mg/kg. Hence 1/10th (200mg/kg) of the drug was selected.
Effect on serum T3, T4 and TSH levels:
There was a significant increase in serum TSH levels in PTU induced wistar rats which confirms the presence of Hypothyroidism. Further it was observed that methanolic extract significantly decrease the levels of TSH (P<0.05) and increase T3 and T4 (P<0.05, P<0.01).
Group |
Treatment |
T3 |
T4 |
TSH |
nmol/L |
nmol/L |
mE/L |
||
I |
Normal Control |
0.75 ± 0.010 |
47.78 ± 0.523 |
1.53 ± 0.136 |
II |
Disease Control |
0.51 ± 0.013 |
22.27 ± 0.580 |
9.51 ± 0.186 |
III |
Standard Control |
0.73 ± 0.012⃰ |
43.65 ± 0.576⃰⃰ |
1.43 ± 0.0147⃰ ⃰ |
IV |
Pet. Ether ext. |
0.73 ± 0.010⃰ |
42.72 ± 0.359⃰ |
1.89 ± 0.044⃰ |
V |
Met. Ext. |
0.73 ± 0.009⃰ |
43.97 ± 0.681⃰ ⃰ |
1.82 ± 0.101⃰ ⃰ |
VI |
Aq. Ext. |
0.72 ± 0.020⃰ |
42.82 ± 0.443⃰ |
1.85 ± 0.161⃰ |
Data are expressed as Mean ± SEM. Where n = 6. P<0.05; P<0.01; P<0.001 compared to PTU [hypothyroid] and normal control (oneway ANOVA followed by Tukey’s post-test)
Effect on Serum lipid profile
There was a significant decrease in cholesterol, triglycerides, VLDL, HDL and LDL levels in PTU induced disease control group as compared to the normal control group. Standard and drug treated group showed some increase in levels of Cholesterol and triglycerides as compared to disease control rats (P<0.05).
Group |
Treat-ment |
Serum Cholesterol |
Serum tri-glycerides |
Serum VLDL |
Serum LDL |
Serum HDL |
mg/dl |
mg/dl |
mg/dl |
mg/dl |
mg/dl |
||
I |
Normal Control |
140.53 ± 0.782 |
105.32 ± 1.153 |
21.30 ± 0.961 |
78.67 ± 1.408 |
20.83 ± 0.688 |
II |
Disease Control |
145.98 ± 1.307 |
95.27 ± 0.960 |
19.92 ± 0.664 |
83.87 ± 0.937 |
19.62 ± 0.512 |
III |
Standard Control |
146.05 ± 1.161⃰ ⃰ |
109.38 ± 1.473⃰ ⃰ |
20.5 ± 0.807⃰ |
81.55 ± 0.597⃰ |
20.82 ± 0.981⃰ |
IV |
Pet. Ether ext. |
147.72 ± 2.330⃰ |
108.22 ± 2.417⃰ |
20.48 ± 0.995⃰⃰ ⃰ |
85.33 ± 0.669 |
20.58 ± 0.897⃰ |
V |
Met. Ext. |
143.92 ± 2.227⃰ |
105.30 ± 1.507⃰ |
22.02 ± 0.993⃰ ⃰ |
82.55 ± 0.781⃰ ⃰ |
21.80 ± 1.002⃰ ⃰ |
VI |
Aq. Ext. |
143.47 ± 3.143⃰ |
105.18 ± 1.704⃰ |
20.77 ± 0.967⃰ |
82.35 ± 0.819⃰ |
20.98 ± 0.981⃰ |
Data are expressed as Mean ± SEM. Where n = 6. P<0.05; P<0.01; P<0.001 compared to PTU [hypothyroid] and normal control (oneway ANOVA followed by Tukey’s post-test)
Effect on liver function tests:
In disease control group, there was a significant increase in serum markers like, Serum glutamic oxaloacetic transaminase (SGOT), Serum glutamic pyruvic transaminase (SGPT) and Alkaline Phosphatase. In contrast, the test drug treated and standard group has shown significant decrease in serum markers in a dose dependent manner (P<0.05).
Group |
Treatment |
SGOT |
SGPT |
Alkaline Phosphatase |
IU/L |
IU/L |
IU/L |
||
I |
Normal Control |
120.80 ± 0.834 |
29.64 ± 0.233 |
99.72 ± 0.331 |
II |
Disease Control |
120.96±0.137 |
30.52±0.158 |
99.91±0.246 |
III |
Standard Control |
120.2 ± 0.237⃰ ⃰ ⃰ |
30.30±0.149⃰ ⃰ ⃰ |
99.4±0.202⃰ ⃰ |
IV |
Pet. Ether ext. |
120.30 ± 0.272⃰ |
30.18 ± 0.087⃰ |
100.36 ± 0.189⃰ |
V |
Met. Ext. |
120.17 ± 0.656⃰ |
30.67 ± 0.147⃰ ⃰ |
99.43 ± 0.559⃰ ⃰ |
VI |
Aq. Ext. |
120.99 ± 157⃰⃰ |
30.06 ± 0.282⃰ |
100.85 ± 0.281⃰ |
Data are expressed as Mean ± SEM. Where n = 6. P<0.05; P<0.01; P<0.001 compared to PTU [hypothyroid] and normal control (oneway ANOVA followed by Tukey’s post-test)
Effect on Hemoglobin, DLC (Differential leukocyte count), TLC (Total Leucocyte Count) and Platelet count
The effect of PTU on Hemoglobin, DLC, TLC and Platelet count showed a marked decrease in all levels and the effect of test groups were found significant as compared to disease control (P<0.001, P<0.05, P<0.01).
Group |
Treatment |
Haemoglobin |
Lympho-cyte |
Mono cyte |
Neutrophil |
g/dl |
% |
% |
% |
||
I |
Normal Control |
13.85 ± 0.102 |
74.83 ± 0.761 |
1.00 ± 0.00 |
24.00 ± 0.850 |
II |
Disease Control |
12.92±0.15 |
64.67±1.122 |
2.66±0.192 |
31± 0.782 |
III |
Standard Control |
13.83±0.307⃰ ⃰⃰ ⃰ |
69.17±0.925 |
1±0.00 |
28.5± 0.697 |
IV |
Pet. Ether ext. |
14.25 ± 0.295⃰ |
67.17 ± 1.065⃰ |
1.00 ± 0.00⃰ |
31.67 ± 0.805⃰ |
V |
Met. Ext. |
13.57 ± 0.192⃰ ⃰ ⃰ |
68.00 ± 1.732⃰ ⃰ ⃰ |
1.00 ± 0.00⃰ |
29.83 ± 1.623⃰ ⃰ |
VI |
Aq. Ext. |
14.37 ± 0.117⃰ ⃰ |
67.00 ± 1.179⃰ ⃰ |
1.00 ± 0.00⃰ |
30.17 ± 0.925⃰ ⃰ |
Data are expressed as Mean ± SEM. Where n = 6. P<0.05; P<0.01; P<0.001 compared to PTU [hypothyroid] and normal control (onewayANOVA followed by Tukey’s post-test)
|
Treatment |
Platelet Count Lac/cmm |
Eosinophils % |
total Leucocyte Count /cumin |
Serum Creatinin % |
I |
Normal Control |
2.14 ± 0.045 |
1.00 ± 0.00 |
7766.67 ± 80.508 |
0.60 ± 0.00 |
II |
Disease Control |
2.62±0.196 |
2±0.236 |
7200±0.00 |
0.578±0.013 |
III |
Standard Control |
2.71±0.116⃰⃰ ⃰⃰ ⃰ |
1±0.00⃰ ⃰ ⃰ |
8616±98.366⃰ |
0.57±0.015⃰⃰ ⃰ |
IV |
Pet. Ether ext. |
2.66 ± 0.079⃰ |
1.17 ± 0.152⃰ |
9633.33 ± 136.761⃰ |
0.59 ± 0.007⃰ |
V |
Met. Ext. |
3.19 ± 0.160⃰ |
1.17 ± 0.152⃰ |
10150.00 ± 290.354⃰ |
0.54 ± 0.015⃰ |
VI |
Aq. Ext. |
3.04 ± 0.072⃰ |
1.33 ± 0.192⃰ |
10366.67 ± 174.271⃰ |
0.55 ± 0.015⃰ |
Data are expressed as Mean ± SEM. Where n = 6. P<0.05; P<0.01; P<0.001 compared to PTU [hypothyroid] and normal control (oneway ANOVA followed by Tukey’s post-test)
Group |
Treatment |
Albumin |
Globulin |
Blood Urea |
Blood Urea Nitrogen |
Total Protein |
g/dl |
g/dl |
mg/dl |
% |
g/dl |
||
I |
Normal Control |
4.35 ± 0.045 |
8.37 ± 0.00 |
18.95 ± 0.00 |
8.90 ± 0.00 |
11.67 ± 0.256 |
II |
Disease Control |
4.31±0.021 |
7.91±0.403 |
19±0.105 |
8.97±0.061 |
12.04±0.344 |
III |
Standard Control |
4.39±0.044⃰ ⃰ |
8.37±0.172⃰ ⃰ ⃰ |
19.01±0.149⃰ |
8.98±0.072⃰ ⃰ |
12.50±0.182⃰ |
IV |
Pet. Ether ext. |
4.32 ± 0.016⃰ |
8.82 ± 0.193⃰ |
18.97 ± 0.097⃰ |
9.03 ± 0.056⃰ |
12.82 ± 0.291⃰ |
V |
Met. Ext. |
4.34 ± 0.016⃰ ⃰ |
8.56 ± 0.177⃰ ⃰ |
19.05 ± 0.062⃰ ⃰ |
8.83 ± 0.056⃰ ⃰ |
13.24 ± 0.107⃰ |
VI |
Aq. Ext. |
4.33 ± 0.025⃰ |
8.85 ± 0.186⃰ ⃰ |
19.04 ± 0.113⃰ |
8.88 ± 0.037⃰ ⃰ |
13.13 ± 0.264⃰ ⃰ |
Data are expressed as Mean ± SEM. Where n = 6. P<0.05; P<0.01; P<0.001 compared to PTU [hypothyroid] and normal control (oneway ANOVA followed by Tukey’s post-test)
Histopathological examination:
Histopathology also supports the results of biochemical analysis. The thyroid tissue of normal group was organized in follicles and interfollicular spaces that contain parafollicular cells and these follicles are oval to round in shape. Thyroid parenchyma is lined by single layer of cuboidal cells. Colloid was found in the lumina of follicles. (Figure1) The hypothyroid tissue slide exhibit interfollicular fibrosis and follicular hyperplasia. Size variation of follicles was also seen in the hypothyroid tissue, vacuolated colloid and interfollicular fibrosis was also observed.(Figure 2). Figure 3, 4 and 6 shows thyroid parenchyma comprises with follicles and lined by cuboidal cells. Figure 5 reveals thyroid parenchyma with hyperplastic nodules and minimal mononuclear infiltration was seen.
Fig. 1 Normal group Fig. 2 Disease control showing
disrupted thyroid follicles
Fig. 3 Standard group Fig. 4 Pet. Ether group
Fig. 5 Meth.Ext.gp Fig. 6 Aq. Ext. group
DISCUSSION:
In the present investigation we have tried to evaluate the effect of different extracts of Alpinia galanga at a dose level of 200mg/kg in PTU induced hypothyroid model of female wistar rats. We found hypothyroid in female wistar rats after one month of PTU induction with the dose of 60µg/kg.
Further the different test groups shows restoring effect in thyroid hormone levels, which shows it was effective in controlling hypothyroidism. As preliminary phytochemical screening of methanolic extract confirms the presence of terpenoids. And Plant derived terpenoids can suppressed nuclear factor-κB (NF-κB) signaling, the major regulato in the pathogenesis of inflammatory disease and cancer. Activation of NF-κB interferes with thyroid hormone production by impairment of t3-dependent induction of 5΄-DI gene expression17. So the triterpenoids present in the extract are thought to be acting in this mechanistic way in treating the Hypothyroidism. Restoration of lipid profile by test group clearly indicates its efficacy against hypothyroidism.
Hypothyroidism also disrupts the liver functions and gets elevated levels of SGOT, SGPT and Alkaline Phosphate. It was found that SGOT, SGPT and Alkaline phosphate was significantly towards normal limits as compared to diseased hypothyroid group.
Disrupted hematological parameters were also restored by methanolic extract of Alpinia galangal. Thus it proves that it is a potent immune stimulator and strengthening agent.
Histological examination also confirms the restoration of cuboidal follicular cells in the test groups when compared to the hyperplasic thyroid follicles in PTU induced disease group. It was already reported that new thyroid follicles were formed by mitotic cell division of parent cell by the process of extra cellular budding.18
ACKNOWLEDGEMENT:
I would like to acknowledge the contribution of Mr. Pankaj Budhlakoti for his continuous support towards this research. I express my sincere gratitude to Dr. Madan Lal Kaushik for trust and guidance during the research and to Dr. Ranjit Singh, Vice Chancellor, Shobhit University, Gangoh for his continuous encouragement.
REFERENCES:
1. Chaker L. Bianco A. C. Jonklaas J. Peeters R. P. Hypothyroidism. Lancet 2017; 390(10101), 1550–1562. doi.org/10.1016/S0140-6736(17)30703-1
2. Yazdani, Darab Tan, Abidin, Zainal E.B, Jaganath. Screening of phytochemical from ethnomedicinal plants in Malaysia for use against toxigenic Aspergillus flavus. Journal of medicinal plant research. 2012; 6(42). 5464-5468. doi: 10.5897/JMPR011.1410
3. Daubresse N. Francesch C. Mhamdi F. Rolando C. A mild synthesis of coumaryl, coniferyl, sinapyl aldehydes and alcohols, Synthesis, 1994; 4, 369-371 doi: 10.1055/s-1994-25477.
4. Lee SJ. Ando T. Optically active 1’acetoxychavicol acetate and its positional isomers: synthesis and repellent effect against adzuki bean weevil, J PesticSci, 2001; 26, 76-81 doi.org/10.1584/jpestics.26.76.
5. Loubinoux B. Miazimbakana J. Gerardin P. Reactivity of new precursors of quinonemethides, Tetrahedron Lett, 1989; 30, 1939-1942 doi.org/10.1016/S0040-4039(00)99619-9.
6. Noro T. Sekiya T. Katoh M. Oda Y. Miyase T. Kuroyanagi M. Ueno A and Fukushima S, Inhibitors of xanthine oxidase from Alpiniagalanga, Chem Pharm Bull, 1988; 36, 244- 248 doi.org/10.1248/cpb.36.244.
7. Itokawa H. Morita H. Sumitomo T. Totsuka N. Takeya K. Antitumour principles from Alpiniag alanga, Planta Med, 1987; 53, 32-33 doi: 10.1055/s-2006-962611.
8. Chouni A. Paul S. A Review on Phytochemical and Pharmacological Potential of Alpinia galanga. Pharmacog J. 2018; 10(1):9-15 doi : 10.5530/pj.2018.1.2.
9. Kubota K. Ueda Y. Yasuda M. Masuda A. Occurrence and antioxidative activity of 1’-acetoxychavicol acetate and its related compounds in the rhizomes of Alpinia galangal during cooking, Spec Publ – R SocChem, 2001; 274, 601-607 doi.org/10.1039/9781847550859-00601.
10. Denys J. Charles. James E. Simon. Singh N K. The Essential Oil of Alpinia galanga Willd., Journal of Essential Oil Research, 1992; 4:1, 81-82, doi: 10.1080/10412905.1992.9698016
11. Salvati S. Attorri L. Campeggi LM. Effect of propylthiouracil induced hypothyroidism on cerebral cortex of young and aged rats: lipid composition of synaptosomes, muscarinic receptor sites, and acetylcholinesterase activity. Neurochem Res. 1994; 19:1181–1186 doi.org/10.1007/bf00965153
12. Cano-Europa E. Blas-Valdivia V. Franco-Colin M. Gallardo-Casas CA. Ortiz-Butro´n R. Methimazole-induced hypothyroidism causes cellular damage in the spleen, heart, liver, lung and kidney. ActaHistochem .2011; 113:1–5 doi: 10.1016/j.acthis.2009.07.004
13. Braca A. Sortino C. Politi M. Morelli I. Mendez J. Antioxidant activity of flavonoids from Licania licaniaeflora, Journal of Ethnopharmacology. 2002; 79(3), 379–381, 2002.doi:10.1016/s0378-8741(01)00413-5.
14. Mandel SJ. Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab. 2001; 86:2354–9. doi: 10.1210/jcem.86.6.7573
15. Yoshihara A, Luo Y, Ishido Y, Usukura K, Oda K, Sue M, Kawashima A, Hiroi N, Suzuki K. Inhibitory effects of methimazole and propylthiouracil on iodotyrosinedeiodinase 1 in thyrocytes. Endocr J. 2019; Apr 25; 66(4):349-357. doi: 10.1507/endocrj.EJ18-0380
16. Afzal M. Kazmi I. Semwal S, Anwar F. Therapeutic exploration of betulinic acid in chemically induced hypothyroidism. Mol Cell Biochem 2014: 386:27-34, doi:10.1007/s11010-013-1842-0
17. Taylor AH. Stephan ZF. Steele RE. Wong NC.Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Mol Pharmacol 1997; 52:542–547. doi: 10.1124/mol.52.3.542
18. Ahmed OM. Abd El-Tawab SM. Ahmed RG.Effects of experimentally induced maternal hypothyroidism and neurotransmitters and adenosinergic system interactions. Int J Dev Neurosci 2010; 28:437–454 doi: 10.1016/j.ijdevneu.2010.06.007.
Received on 04.08.2021 Modified on 15.12.2021
Accepted on 07.03.2022 © RJPT All right reserved
Research J. Pharm. and Tech 2022; 15(10):4372-4376.
DOI: 10.52711/0974-360X.2022.00733